Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashExchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Spyre Therapeutics (SYRE) Exchange Rate Effect: 2020-2024

Historic Exchange Rate Effect for Spyre Therapeutics (SYRE) over the last 4 years, with Dec 2024 value amounting to -$15,000.

  • Spyre Therapeutics' Exchange Rate Effect fell 183.33% to -$15,000 in Q4 2024 from the same period last year, while for Dec 2024 it was $15,000, marking a year-over-year decrease of 40.00%. This contributed to the annual value of -$3,000 for FY2024, which is 112.00% down from last year.
  • Spyre Therapeutics' Exchange Rate Effect amounted to -$15,000 in Q4 2024, which was down 193.75% from $16,000 recorded in Q3 2024.
  • Spyre Therapeutics' Exchange Rate Effect's 5-year high stood at $47,000 during Q4 2020, with a 5-year trough of -$72,000 in Q2 2022.
  • For the 3-year period, Spyre Therapeutics' Exchange Rate Effect averaged around -$7,636, with its median value being -$4,000 (2024).
  • Within the past 5 years, the most significant YoY rise in Spyre Therapeutics' Exchange Rate Effect was 1,433.33% (2022), while the steepest drop was 1,900.00% (2022).
  • Quarterly analysis of 5 years shows Spyre Therapeutics' Exchange Rate Effect stood at $47,000 in 2020, then crashed by 93.62% to $3,000 in 2021, then surged by 1,433.33% to $46,000 in 2022, then tumbled by 60.87% to $18,000 in 2023, then crashed by 183.33% to -$15,000 in 2024.
  • Its last three reported values are -$15,000 in Q4 2024, $16,000 for Q3 2024, and -$4,000 during Q1 2024.